Esanik Therapeutics, Inc. funding
Esanik Therapeutics, Inc., a pharmaceuticals company based in Northville, MI, filed a Form D with the SEC on April 30, 2026 and reported $200K raised of a $375K offering.
Amount raised$200K
Offering size$375K
Filed with the SECApril 30, 2026
First saleApril 6, 2026
IndustryPharmaceuticals
SecuritiesEquity, Debt
LocationNorthville, MI
FoundedMore than 5 years ago
Entity typeCorporation
Investors so far1
Minimum investment—
Revenue rangeDecline to Disclose
View the original Form D on SEC EDGAR ↗ · All rounds filed Apr 30